← back to search
Natalie Shapnik
Memorial Sloan Kettering Cancer Center
· US
Area of research
Pulmonary and Respiratory Medicine · Molecular Biology
Research interest
Research interests include Renal cell carcinoma treatment, Renal and related cancers, Cancer Genomics and Diagnostics, and Cancer Immunotherapy and Biomarkers.
h-index
7
citations
428
works
22
NIH funding
—
primary concept
Medicine
email
✉ Find email ↗
Recent publications
Phase II Trial of Cabozantinib Plus Nivolumab in Patients With Non–Clear-Cell Renal Cell Carcinoma and Genomic Correlates
Journal of Clinical Oncology
2022
cited by
191
position: middle
doi
Grants
No grants ingested yet.
Frequent collaborators
Andrew Leonard Laccetti
· Spanish Oncology Genitourinary Group
1
papers (2022–2022)
Colette Owens
· General Department of Preventive Medicine
1
papers (2022–2022)
Robert A. Lefkowitz
· Cornell University
1
papers (2022–2022)
Neil J. Shah
· Bellevue Hospital Center
1
papers (2022–2022)
Robert J. Motzer
· Texas Oncology
1
papers (2022–2022)
David H. Aggen
· New York Oncology Hematology
1
papers (2022–2022)
Mark Zucker
· Kettering University
1
papers (2022–2022)
Maria I. Carlo
· Clinica Mediterranea
1
papers (2022–2022)
Ed Reznik
· Motlow State Community College
1
papers (2022–2022)
Martin H. Voss
· Spanish Oncology Genitourinary Group
1
papers (2022–2022)
Ying‐Bei Chen
· Johns Hopkins University
1
papers (2022–2022)
Darren R. Feldman
· Weill Cornell Medicine
1
papers (2022–2022)
Chung‐Han Lee
· Exelixis (United States)
1
papers (2022–2022)
Deaglan Joseph McHugh
· Weill Cornell Medicine
1
papers (2022–2022)
Ritesh R. Kotecha
· Spanish Oncology Genitourinary Group
1
papers (2022–2022)
Chloe Dadoun
· Memorial Sloan Kettering Cancer Center
1
papers (2022–2022)
Andrea Knežević
· University of Zagreb
1
papers (2022–2022)